Pendal Group LTD Hutchmed (China) LTD Transaction History

Pendal Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 30, 2019	SELL	$23.09 - $37.69 $361,935 - $590,790	-15,675 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$26.55 - $34.38 $66,136 - $85,640	-2,491 Reduced 13.71%	15,675 $0
Q2 2018 Jul 18, 2018	BUY	$27.79 - $34.49 $34,181 - $42,422	1,230 Added 7.26%	18,166 $0
Q1 2018 May 08, 2018	BUY	$28.87 - $41.13 $488,942 - $696,577	16,936 New	16,936 $0

8.25M

3.8K

2.4K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.11B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

Stay updated on Pendal Group LTD with notifications on news.